The Miami Entrepreneur

Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth 

Read Time:6 Second

Merck on Thursday reported first-quarter results that beat analysts’ expectations amid strong sales of vaccines and cancer drug Keytruda.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Chip sector due a May bounce with Nvidia near ‘trough valuation,’ say Bank of America strategists
Next post Retirees feel good about money and life, but worry about inflation and Social Security